Opinion: Blue blood on the streets
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Email
  • Free trial
  • Log in

Opinion: Blue blood on the streets

Mark Geoghegan
23 March 2018
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Email

If Lloyd's aggregate results were not already shock enough, yesterday's exclusive revelation that MS Amlin was a £1.4bn ($2bn) capacity outlier within that £33bn whole ripped down Lime Street like a lightning bolt.

Subscribers, log in here:

Fuel a smarter strategy with our actionable market intelligence

      • Gain a competitive edge and accelerate decision-making
      • Be empowered by insights that transform confusion to clarity
      • Uncover growth opportunities and prepare for potential threats
      • Fuel a smarter strategy for business growth
Request a free trial Already a subscriber? Log in now

Topics

News Reinsurers M&A Results
MG
Mark Geoghegan
Gift this article